Programme of Assessing the Risk of Dementia
The widespread prevalence of Alzheimer's disease is rising hand in hand with the increase in average life expectancy. With an incidence of 10% at age 60 that reaches 50% at 80, it can be a concern for anyone experiencing the feeling of forgetfulness. However, not every case of forgetfulness leads to or is associated with Alzheimer's. People who suffer from a degree of forgetfulness without losing their ability to perform daily duties may be diagnosed with ‘Mild Cognitive Impairment’. It has been scientifically proven that this group is more prone to Alzheimer's disease. It is also possible to research who carries a higher risk factor. In this program, studies and research are focused on the higher risk patients; preventive rehabilitation and therapy is planned. Alzheimer's disease cannot be prevented, but its onset can be delayed.
Research Programme
- 1. Routine medical history and neurological examination, familial burden, creating a family tree to see if there are people in the family with dementia.
- Laboratory tests:
- Beta-amyloid 42 / Beta 40 values
- APOE genotyping, presenile genetic screening
- Tests for plasma lipid profile and thyroid function, B12 and folate levels
- Neurophysiological tests: the test of cognitive performance in people diagnosed with ‘Mild Cognitive Impairment’ has low values. Various tests are used for this diagnosis. A scoring system identifies the degree of risk using a series of tests that last about 30 minutes. Another important indication is when these parameters show a downward trend at follow-up examinations every 6 months. The tests we are generally willing to carry out are as follows:Bender-Gestalt
- Wechsler Adult Intelligence Scale (WAIS)
- Organizational Memory
- Brief Cognitive Assessment Scale
- Depression Scale
After these tests, all results are evaluated and a specific opinion is formed about the degree of risk of dementia. People at high risk:
- Electroencephalography (cortical mapping)
- Magnetic resonance imaging (amyloid imaging and volumetric studies)
- PET-scans are recommended.
LIV HOSPITAL will not under any circumstances share your test results with any third party or person without your express permission and consent.